AD353

AD353 is a potent and selective sigma-1 receptor ligand with demonstrated efficacy in preclinical models of neuropathic pain, including capsaicin-induced allodynia and PGE2-induced hyperalgesia. Its favorable pharmacokinetic profile supports its utility in both in vitro binding studies and in vivo pain research.